fbpx Skip to main content

WEDNESDAY, Jan. 20, 2021 (HealthDay News) — Abnormalities detected on noninvasive retinal imaging are associated with markers of cognitive dysfunction in older individuals with type 1 diabetes, according to a study published online Dec. 30 in the Journal of Clinical Endocrinology & Metabolism.

Ward Fickweiler, M.D., from the Joslin Diabetes Center in Boston, and colleagues conducted complete cognitive testing, optical coherence tomography (OCT), and OCT angiography (OCTA) on 129 participants with 50 or more years of type 1 diabetes.

The researchers found that decreased vessel density of the superficial retinal capillary plexus and deep retinal capillary plexus was associated with worse delayed memory and dominant hand psychomotor speed. Worse psychomotor speed in both nondominant and dominant hands was associated with thinning of the retinal outer nuclear layer. Delayed memory was associated with outer plexiform layer thickness.

“These findings suggest that noninvasive retinal imaging using OCT and OCTA may assist in estimating the risks for cognitive dysfunction in people with type 1 diabetes,” the authors write.

Abstract/Full Text (subscription or payment may be required)

You May Also Like::  Effects of Healthcare Disruptions During the Pandemic on Diabetic Veterans

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More